Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Accumulated Depreciation & Amortization (2016 - 2017)

Historic Accumulated Depreciation & Amortization for Tenax Therapeutics (TENX) over the last 5 years, with Q3 2017 value amounting to $573025.0.

  • Tenax Therapeutics' Accumulated Depreciation & Amortization fell 519.03% to $573025.0 in Q3 2017 from the same period last year, while for Sep 2017 it was $573025.0, marking a year-over-year decrease of 519.03%. This contributed to the annual value of $567625.0 for FY2016, which is N/A changed from last year.
  • Latest data reveals that Tenax Therapeutics reported Accumulated Depreciation & Amortization of $573025.0 as of Q3 2017, which was down 519.03% from $575081.0 recorded in Q2 2017.
  • In the past 5 years, Tenax Therapeutics' Accumulated Depreciation & Amortization registered a high of $999003.0 during Q1 2013, and its lowest value of $567625.0 during Q4 2016.
  • Over the past 4 years, Tenax Therapeutics' median Accumulated Depreciation & Amortization value was $604395.0 (recorded in 2016), while the average stood at $691828.6.
  • In the last 5 years, Tenax Therapeutics' Accumulated Depreciation & Amortization plummeted by 2417.55% in 2016 and then tumbled by 519.03% in 2017.
  • Quarter analysis of 4 years shows Tenax Therapeutics' Accumulated Depreciation & Amortization stood at $828752.0 in 2013, then dropped by 9.67% to $748604.0 in 2015, then decreased by 24.18% to $567625.0 in 2016, then increased by 0.95% to $573025.0 in 2017.
  • Its Accumulated Depreciation & Amortization was $573025.0 in Q3 2017, compared to $575081.0 in Q2 2017 and $571657.0 in Q1 2017.